Bridges4Kids Logo

 
Home ] What's New ] Contact Us ] About Us ] Links ] Search ] Glossaries ] Contact Legislators ] Reviews ] Downloads ] Disabilities ] IDEA ] Special Education ] Medicaid/SSI ] Childcare/Respite ] Wraparound ] Insurance ] PAC/SEAC ] Ed Reform ] Literacy ] Community Schools ] Children At-Risk ] Section 504 ] School Climate/Bullying ] Parenting/Adoption ] Home Schooling ] Community Living ] Health & Safety ] Summer Camp ] Kids & Teens ] College/Financial Aid ] Non-Public & Other Schools ] Legal Research ] Court Cases ] Juvenile Justice ] Advocacy ] Child Protective Services ] Statistics ] Legislation ] Ask the Attorney ]
 
 Where to find help for a child in Michigan, Anywhere in the U.S., or Canada
 
Bridges4Kids is now on Facebook. Follow us today!
 
Last Updated: 10/31/2017
 

Article of Interest - Medication

Printer-friendly Version

Bridges4Kids LogoParents: Kids Face Antidepressants Risk
by Lauran Neergaard, Associated Press, February 2, 2004
For more articles like this visit http://www.bridges4kids.org

 

Parents pleaded with the Food and Drug Administration on Monday to end the use of popular adult antidepressants in children, saying the drugs can increase youths' risk of suicide and violence.

"To die in this violent, unusual fashion without making a sound ... Paxil must have put her over the edge," said Sara Bostock, describing how her daughter Cecily stabbed herself in the chest with a kitchen knife shortly after graduating from Stanford University and two weeks after starting the drug.

"You have an obligation today ... from preventing this tragic story from being repeated over and over again," said Mark Miller of Kansas City, Mo., whose son Matt hanged himself from his bedroom closet after taking his seventh Zoloft tablet.

But facing those anguished complaints were a handful of families who say antidepressants changed their children's lives by alleviating serious depression.

"My children have had tremendous improvement with their illnesses," said Dr. Suzanne Vogel-Scieilia of the National Alliance for the Mentally Ill, who has two sons using the drugs. "I shudder to think of their plight if these medicines were not available."

The FDA opened hearings Monday on the emotionally charged controversy, months after British health authorities first sounded the alarm by saying an entire list of antidepressants were unsuitable for child use.

Here, no final answer is expected until late summer. Until then FDA has advised doctors to use great caution if they prescribe any antidepressants to anyone under age 18.

"The wrong answer in either direction ... could have profound consequences," said Dr. Russell Katz, FDA's director of neurologic drugs, in explaining the lengthy deliberation.

Katz acknowledged divisions of opinion even within the FDA, where some scientists believe there is a link between some antidepressants and youth suicide behavior and attempts.

No studies have occurred in studies encompassing 4,000 children. Preliminary data, however, suggest that suicidal behavior and attempts, while infrequent, might be at least twice as frequent among some antidepressant users. Britain put the risk at around 3.2 percent of children given the drugs, compared with 1.5 percent of those given dummy pills.

But problems with that data led FDA's leaders to conclude that they can't yet answer the question.

Depression occurs in about 10 percent of youth and can lead to suicide, especially if untreated. Some 1,883 10- to 19-year-olds killed themselves in 2001, and specialists say there are 10 to 20 attempts for every suicide.

For adults, antidepressants clearly alleviate major depression, the FDA stresses.

But medicines can work differently in children. The agency has approved only one treatment _ Prozac, the best known of a family of popular antidepressants called SSRIs _ to alleviate pediatric depression, saying its benefits outweigh side effects.

Still, it is legal for doctors to prescribe adult medicines to children even if the FDA has not formally approved pediatric use, and child antidepressant prescriptions rose dramatically in the 1990s. The FDA ordered other manufacturers to submit research on how their drugs affect children and teenagers.

Last summer, British health authorities acted on the first of those findings, declaring that no depressed child or teen should use the SSRI drug Paxil, sold in Britain under the name Seroxat.

The FDA still is analyzing the studies.

The reports of suicidal behavior are a hodgepodge difficult to sort out, Katz said. Some cases counted as unintentional drug overdoses may not have been, for example, while others termed suicidal were caused by a mental illness called self-mutilation, where children make small cuts over their bodies. Sorting out just what happened is crucial to settling the issue, Katz said.

For Monday's hearing, the FDA brought together its scientific advisers to ask if it is analyzing the research appropriately, and if families or doctors need additional advice in the meantime.

It's a debate eliciting strong emotions.

The American College of Neuropsychopharmacology, considered the field's top specialists, last month declared evidence that links SSRIs to suicide too weak to justify not using them. The group points to evidence that suicides have dropped as SSRI use increased around the world, and to autopsy studies that show most suicides hadn't taken an anti-depressant, or the right dose, just before their deaths.

On the other side, critics claim SSRIs sometimes cause agitation and urgent anxiety, called akathisia, that could make certain people suicidal. Dr. David Healy, a Welsh physician who pushed for Britain's crackdown, says even he prescribes the drugs, but that they must come with warnings so doctors can monitor children for signs of trouble.

    

back to the top     ~     back to Breaking News     ~     back to What's New

 

Thank you for visiting http://www.bridges4kids.org/.
 

bridges4kids does not necessarily agree with the content or subject matter of all articles nor do we endorse any specific argument.  Direct any comments on articles to deb@bridges4kids.org.

 

2002-2017 Bridges4Kids